Literature DB >> 17103364

[NeuroCogFX--a computer-based neuropsychological assessment battery for the follow-up examination of neurological patients].

K Fliessbach1, C Hoppe, U Schlegel, C E Elger, C Helmstaedter.   

Abstract

Many neurological therapeutic trials require a longitudinal assessment of cognitive functions. An ideal instrument for that purpose should be in accordance to the criteria of classical testing theory and, furthermore, it should be repeatable and economic in administration and interpretation. We developed NeuroCogFX, a computerized assessment battery, according to these criteria. NeuroCogFX comprises subtests for short term memory, working memory, psychomotor speed, selective attention, verbal and figural memory and verbal fluency (mean duration: 25 minutes). Age-related normative data was obtained from 244 subjects without history of neurological or psychiatric disease (age range 16 - 75 years). Forty-two subjects were re-tested after an average of 8 weeks (range: 6 - 10 weeks) in order to assess retest reliability and training effects. Retest-reliabilities were middle-sized in all but one subtest, ranging from r (12) = 0.5 to r (12) = 0.7 (2-back Test: r (12) = 0.37). For construct validation NeuroCogFX was administered in addition to a comprehensive neuropsychological assessment battery in a group of 40 healthy subjects and in 42 patients with chronic epilepsy. The test allows a valid assessment of short-term memory, reaction speed, memory and verbal fluency. NeuroCogFX is an economic, sufficiently reliable and valid instrument for the neuropsychological follow-up examination in single patients and study groups which can be administered if a comprehensive neuropsychological assessment is unavailable.

Entities:  

Mesh:

Year:  2006        PMID: 17103364     DOI: 10.1055/s-2006-932162

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  13 in total

1.  Computer-based assessment of cognitive functions in brain tumor patients.

Authors:  Klaus Fliessbach; Sabine Rogowski; Christian Hoppe; Michael Sabel; Mathias Goeppert; Christoph Helmstaedter; Pasquale Calabrese; Gabriele Schackert; Joerg-Christian Tonn; Matthias Simon; Uwe Schlegel
Journal:  J Neurooncol       Date:  2010-05-07       Impact factor: 4.130

2.  Improving digit span assessment of short-term verbal memory.

Authors:  David L Woods; Mark M Kishiyamaa; E William Lund; Timothy J Herron; Ben Edwards; Oren Poliva; Robert F Hink; Bruce Reed
Journal:  J Clin Exp Neuropsychol       Date:  2011-01       Impact factor: 2.475

3.  A prospective study on neurocognitive effects after primary radiotherapy in high-grade glioma patients.

Authors:  Raphael Bodensohn; Stefanie Corradini; Ute Ganswindt; Jan Hofmaier; Oliver Schnell; Claus Belka; Maximilian Niyazi
Journal:  Int J Clin Oncol       Date:  2015-12-22       Impact factor: 3.402

4.  Complete response to therapy: why do primary central nervous system lymphoma patients not return to work?

Authors:  Greta Wiemann; Milena Pertz; Uwe Schlegel; Patrizia Thoma; Thomas Kowalski; Sabine Seidel
Journal:  J Neurooncol       Date:  2020-07-31       Impact factor: 4.130

Review 5.  Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors.

Authors:  Marco Mula; Michael R Trimble
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

6.  Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6.

Authors:  Ina Klinke; Martina Minnerop; Tanja Schmitz-Hübsch; Marc Hendriks; Thomas Klockgether; Ullrich Wüllner; Christoph Helmstaedter
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

Review 7.  [Hearing and cognition: neurocognitive test batteries in otorhinolaryngology].

Authors:  C Völter; L Götze; U Bruene-Cohrs; S Dazert; J P Thomas
Journal:  HNO       Date:  2020-03       Impact factor: 1.284

8.  The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease.

Authors:  Martina Minnerop; Bernd Weber; Jan-Christoph Schoene-Bake; Sandra Roeske; Sandra Mirbach; Christian Anspach; Christiane Schneider-Gold; Regina C Betz; Christoph Helmstaedter; Marc Tittgemeyer; Thomas Klockgether; Cornelia Kornblum
Journal:  Brain       Date:  2011-11-29       Impact factor: 13.501

9.  Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study.

Authors:  Carla Gliem; Martina Minnerop; Sandra Roeske; Hanna Gärtner; Jan-Christoph Schoene-Bake; Sandra Adler; Juri-Alexander Witt; Felix Hoffstaedter; Christiane Schneider-Gold; Regina C Betz; Christoph Helmstaedter; Marc Tittgemeyer; Katrin Amunts; Thomas Klockgether; Bernd Weber; Cornelia Kornblum
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

Review 10.  Neurocognitive Changes in Spinocerebellar Ataxia Type 3: A Systematic Review with a Narrative Design.

Authors:  Kah Hui Yap; Roy P C Kessels; Shahrul Azmin; Bart van de Warrenburg; Norlinah Mohamed Ibrahim
Journal:  Cerebellum       Date:  2021-07-07       Impact factor: 3.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.